Outcome of sporadic amyotrophic lateral sclerosis treated With non-invasive ventilation and riluzole Sobrevida en pacientes con esclerosis lateral amiotrófica esporádica tratados con ventilación no invasiva y riluzole

Article English OPEN
Martín Sívori; Gabriel E. Rodríguez; Daniel Pascansky; César Séenz; Roberto E. P. Sica;
(2007)
  • Publisher: Fundación Revista Medicina
  • Journal: Medicina (Buenos Aires) (issn: 0025-7680, eissn: 1669-9106)
  • Subject: Esclerosis lateral amiotrófica | Sobrevida | Ventilación no invasiva | Riluzole | Amyotrophic lateral sclerosis | Survival | Non invasive ventilation | Riluzole | Medicine | R | Immunologic diseases. Allergy | RC581-607 | Infectious and parasitic diseases | RC109-216

Sporadic amyotrophic lateral sclerosis (sALS) is a progressive degenerative motor neuron disorder lacking specific treatment. Riluzole is the only drug able to modestly slow down the course of the disease. Respiratory insufficiency is the main cause of death; non invasi... View more
Share - Bookmark